Modification of some biological properties of HeLa cells containing adeno-associated virus DNA integrated into chromosome 17
about
Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levelsA common mechanism for cytoplasmic dynein-dependent microtubule binding shared among adeno-associated virus and adenovirus serotypes.Adeno-associated virus site-specifically integrates into a muscle-specific DNA regionDefinition of herpes simplex virus type 1 helper activities for adeno-associated virus early replication eventsHuman adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses.Adeno-associated virus major Rep78 protein disrupts binding of TATA-binding protein to the p97 promoter of human papillomavirus type 16Adeno-associated virus sensitizes HeLa cell tumors to gamma rays.Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination.Transduction of folate receptor cDNA into cervical carcinoma cells using recombinant adeno-associated virions delays cell proliferation in vitro and in vivo.Binding sites for adeno-associated virus Rep proteins within the human genome.Differential suppression of the tumorigenicity of HeLa and SiHa cells by adeno-associated virus.Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro.Detection of adeno-associated virus type 2 genome in cervical carcinoma.Characterization of cell lines that inducibly express the adeno-associated virus Rep proteinsIdentification of an adeno-associated virus Rep protein binding site in the adenovirus E2a promoter.Adeno-associated virus Rep78 protein interacts with protein kinase A and its homolog PRKX and inhibits CREB-dependent transcriptional activationKinetics and frequency of adeno-associated virus site-specific integration into human chromosome 19 monitored by quantitative real-time PCR.High-level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is sufficient for infectious-particle formation by a rep-negative AAV mutant.Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome.Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins.Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins.Cell lines inducibly expressing the adeno-associated virus (AAV) rep gene: requirements for productive replication of rep-negative AAV mutants.Analysis of the terminal repeat binding abilities of mutant adeno-associated virus replication proteins.Herpes simplex virus type 1 ICP0 protein mediates activation of adeno-associated virus type 2 rep gene expression from a latent integrated form.Impact of the interaction between herpes simplex virus type 1 regulatory protein ICP0 and ubiquitin-specific protease USP7 on activation of adeno-associated virus type 2 rep gene expression.High Prevalence of Infectious Adeno-associated Virus (AAV) in Human Peripheral Blood Mononuclear Cells Indicative of T Lymphocytes as Sites of AAV Persistence.Impact of the MRN Complex on Adeno-Associated Virus Integration and Replication during Coinfection with Herpes Simplex Virus 1.
P2860
Q24646235-2BDC7C5C-7A50-41BF-8017-7164F9DB7BFDQ30445618-8E8964B0-4108-4847-88F1-376F02DE8D30Q31637262-ADBFBE0B-7672-48AA-9F55-C6BA26794B99Q33417647-67052F47-FC8F-4084-AD35-B7F01CE0432FQ33640090-22BC8B2E-6508-497A-B563-B51BCD64046FQ33799345-30B063A4-E55F-4838-8E86-17AE2F3F749BQ33937430-E94A38C0-5E06-44A2-8139-22D8BDDF36E5Q33938668-A2386031-4A65-4E74-B6F6-0698B4D12F0FQ35763351-9272E03C-4E9D-4AB8-883C-A3DC1467CB0BQ35879908-9EAFB1D6-4797-435E-B4B4-DDDB9B949250Q36135340-FD0AEED4-9265-46B3-AB51-96B89552FBEDQ36548752-46FD8EB4-64F6-476F-9523-8295A03A5923Q36614427-E327362D-0FC6-44EF-8099-95A3DDB36C9FQ36624044-825D54DC-AF87-4FC9-A418-763E39D26D46Q37748110-7491F651-0D68-44C3-995F-3E02EDC9C2D7Q39581069-DD00514A-2AB3-4532-B59E-07273B7DA656Q39684290-03388F66-05F0-4D30-AA1F-D386EF94C529Q39872328-6F472611-8E18-49C1-8173-237988C0635BQ39879196-385D5750-31EE-4309-BCF7-FADC59DA927DQ39880567-078382DA-EE83-42DF-88E6-CB7E120F1AD1Q39882175-2BB76436-7708-4ADB-9BE1-5710DF93228BQ40042369-95B1DAC5-6535-4EF0-8E8B-BE0DB16E568EQ40046229-5E62AA42-B04E-4972-AF16-3A11CBA24714Q40161739-9701DBC9-659D-44DC-BCA1-24A1BD71D2AEQ40304876-A766519D-D895-402E-99AF-61CF95FA7C3DQ40419511-0C733EE3-B4D8-4C32-8FE2-F3E4B2D64931Q41295569-A46A816F-6A87-4415-9648-4EE5D3712FDB
P2860
Modification of some biological properties of HeLa cells containing adeno-associated virus DNA integrated into chromosome 17
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Modification of some biologica ...... integrated into chromosome 17
@ast
Modification of some biologica ...... integrated into chromosome 17
@en
type
label
Modification of some biologica ...... integrated into chromosome 17
@ast
Modification of some biologica ...... integrated into chromosome 17
@en
prefLabel
Modification of some biologica ...... integrated into chromosome 17
@ast
Modification of some biologica ...... integrated into chromosome 17
@en
P2860
P1433
P1476
Modification of some biologica ...... integrated into chromosome 17
@en
P2093
P2860
P304
P407
P577
1992-05-01T00:00:00Z